Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKainos Group Regulatory News (KNOS)

Share Price Information for Kainos Group (KNOS)

Share Price is delayed by 15 minutes
Get Live Data
849.50    -28.50 (-3.25%)
Bid:
852.50
Ask:
854.50
Spread: 2.00 (0.235%)
Market Cap: £978.40m
KNOS Live PriceLast checked at - London Stock Exchange

Intraday Kainos Group Share Chart

Director/PDMR Shareholding

8 Aug 2018 14:21

RNS Number : 2339X
Kainos Group plc
08 August 2018
Ā 

08 August 2018

Ā 

Kainos Group plc

Ā 

("Kainos" or the "Company)

Director and PCA Dealing

Ā 

The Company was notified on 08 August 2018 that Richard McCann, Director, has:

Ā 

1. exercised his 2015 PSP options over 68,345 ordinary shares of £0.005 in the Company ("Ordinary Shares"), at an exercise price of £0.005 per Ordinary Share; and

2. exercised his 2015 SAYE options over 3,237 Ordinary Shares at an exercise price of £1.112 per Ordinary Share; and

3. received a nil value transfer of 100,000 Ordinary Shares from his spouse/Person Closely Associated ("PCA").

Ā 

Following this notification, having retained the PSP and SAYE Ordinary Shares on exercise, Richard McCann and his PCA have a reportable shareholding of 6,211,582 Ordinary Shares in the issued share capital of the Company, constituting 5.19% of the issued share capital of the Company.

Ā 

Ā 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Richard McCann

2.

Reason for the notification

a.

Position/status

COO/CFO & PDMR

b.

Initial notification

/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Kainos Group plc

b.

LEI

213800H2PQMIF3OVZY47

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument/

type of instrument

Identification code

Ordinary Shares of £0.005 each

Ā 

Ā 

ISIN: GB00BZ0D6727

b.

Nature of the transaction

Exercise of Options and Retention of Shares

Transfer of Shares from Spouse

c.

Price(s) and volume(s)

EXERCISE OF2015 PSP

Price(s)

Volume(s)

Ā£0.005

68,345

Ā 

EXERCISE OF2015 SAYE

Price(s)

Volume(s)

Ā£0.005

3,237

Ā 

TRANSFER OF SHARES FROM SPOUSE

Price(s)

Volume(s)

NIL

100,000

d.

Aggregated information

Ā· Aggregated volume

Ā· Price

Ā 

N/A

e.

Date of the transaction

PSP exercise and transfer to spouse - 07 August 2018

SAYE exercise - 08 August 2018

f.

Place of the transaction

Outside a trading venue

Ā 

Ā 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Kerry McCann

2.

Reason for the notification

a.

Position/status

PCA of Richard McCann (PDMR)

b.

Initial notification

/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Kainos Group plc

b.

LEI

213800H2PQMIF3OVZY47

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument/

type of instrument

Identification code

Ordinary Shares of £0.005 each

Ā 

Ā 

ISIN: GB00BZ0D6727

b.

Nature of the transaction

Transfer to Spouse

c.

Price(s) and volume(s)

Ā 

TRANSFER OF SHARES TO SPOUSE

Price(s)

Volume(s)

Nil

100,000

d.

Aggregated information

Ā· Aggregated volume

Ā· Price

Ā 

N/A

e.

Date of the transaction

07 August 2018

f.

Place of the transaction

Outside a trading venue

Ā 

Ā 

Classification: Additional Regulated Information

Ā 

Ā 

Ends

Ā 

For further information, please contact:

Ā 

Kainos via FTI Consulting LLP

Brendan Mooney, Chief Executive Officer

Richard McCann, Chief Financial Officer

Ā 

Investec Bank plc 44Ā 20 7597 5970

Patrick Robb / Sebastian Lawrence

Ā 

Canaccord Genuity +44 20 7523 4606

Simon Bridges / Emma Gabriel

Ā 

FTI Consulting LLP +44 20 3727 1000

Matt Dixon / Harry Staight

Ā 

About Kainos

Kainos Group plc is a UK-based provider of Digital Services and Digital Platforms.

Ā 

The Group's Digital Services include full lifecycle development and support of customised Digital Services for government and commercial customers. Kainos is also the leading European partner for Workday Inc. ('Workday') responsible for implementing Workday's innovative Software-as-a-Service (SaaS) platform for enterprise and, now, government customers.

Ā 

The Group's Digital Platforms comprise specialised digital products in the mobile healthcare and automated testing arenas. Smart is an automated testing platform for Workday customers; Evolve Electronic Medical Records ('EMR') is the market leading product for the digitisation of patient notes in the Acute sector of the NHS; and Evolve Integrated Care ('IC') is a SaaS-based integrated care platform for the NHS and international healthcare providers; and Smart is an automated testing platform for Workday customers.

Ā 

Kainos has over 1,150 people across eleven offices in Europe and the USA, working interchangeably across its Services and Platforms divisions.

Ā 

Kainos is listed on the London Stock Exchange (LSE: KNOS). For further information, please visit www.kainos.com

Ā 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Ā 
END
Ā 
Ā 
DSHFKFDDNBKDCFK
Date   Source Headline
4th Jun 202611:31 amRNSDirector / PDMR shareholdings
1st Jun 202610:27 amRNSTotal Voting Rights
18th May 20267:00 amRNSFull Year Results
18th May 20267:00 amRNSTransaction in Own Shares
12th May 20267:00 amRNSTransaction in Own Shares
6th May 20267:00 amRNSTransaction in Own Shares
1st May 202611:06 amRNSTotal Voting Rights
28th Apr 20261:38 pmRNSBoard and Board Committee Changes
28th Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSYear-end Trading Update
14th Apr 20267:00 amRNSTransaction in Own Shares
8th Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 202610:22 amRNSTotal Voting Rights
31st Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20265:10 pmRNSDirector Declaration
24th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20263:16 pmRNSNotification of Major Holdings
17th Mar 202611:28 amRNSDirector/PDMR shareholdings
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20264:58 pmRNSNotification of Transactions of Director/PDMR
12th Mar 20262:13 pmRNSHolding(s) in Company
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20269:30 amRNSTotal Voting Rights
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20269:43 amRNSTotal Voting Rights
2nd Feb 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.